Annnouncements
15 April 2024
We are still accepting manuscripts for COVID 19 Special Issue “Methods to Facilitate SARS CoV 2 and COVID 19 Research”
The botulinum neurotoxin type A (BoNT/A) is a neurotoxin produced by Clostridium botulinum. It causes botulism and represents the most powerful natural poison. In urological practice, the indications for BoNT/A therapy include neurogenic detrusor overactivity (NDO), idiopathic overactive bladder (OAB) or idiopathic detrusor overactivity (IDO), detrusor-sphincter dyssynergia (DSD), interstitial cystitis/bladder pain syndrome (IC/BPS), urinary tract […]Fan Zhang, Qinggang Liu, Limin Liao, Xiaojuan Li, Xueping Zhang
15 April 2024
Safety and Effectiveness of Nustim System Implantation in Dogs
Objectives: To verify the safety and effectiveness of a novel micro-implantable wireless nerve stimulation device in healthy adult beagles and evaluate the feasibility of using the device in clinical practice. Methods: The stimulator was experimentally implanted into the quadriceps femoris of three adult beagles. The animals were subjected to training on daily basis for 14 […]Xing Li, Han Deng, Zhaoxia Wang, Hao Li, Limin Liao
15 April 2024
Chinese botulinum toxin A for the treatment of lower urinary tract dysfunction
The novel 2019 coronavirus disease (COVID-19) pandemic has impacted all of us in difficult ways and is affecting millions of people around the globe. It has created a tremendous health burden and unexpected challenges for research. However, rapid detection, tracking, and characterization of the SARS-CoV-2 virus and COVID-19 disease….